Recurrent Acute Biphenotypic Leukemia Active Not Recruiting Phase 2 Trials for Cedazuridine (DB15694)

Also known as: Acute, recurrent Biphenotypic Leukemia

Indication	Status	Phase
DBCOND0106027 (Recurrent Acute Biphenotypic Leukemia)	Active Not Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04975919	Venetoclax in Combination with Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia	Treatment	Cedazuridine (DB15694) Decitabine (DB01262) Venetoclax (DB11581)